Jacobs Levy Equity Management, Inc Dexcom Inc Transaction History

Jacobs Levy Equity Management, Inc

$25.8 Billion
Q4 2024

A detailed history of Jacobs Levy Equity Management, Inc transactions in Dexcom Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 77,401 shares of DXCM stock, worth $7.01 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

77,401

Previous 34,609 123.64%

Holding current value

$7.01 Million

Previous $2.32 Million 159.55%

% of portfolio

0.02%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$65.68 - $81.01 $2.81 Million - $3.47 Million	42,792 Added 123.64%	77,401 $6.02 Million
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $1.92 Million - $3.49 Million	30,058 Added 660.47%	34,609 $2.32 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $225,262 - $370,493	-2,984 Reduced 39.6%	4,551 $564,000
Q3 2023 Nov 16, 2023	SELL	$86.06 - $137.93 $1.32 Million - $2.11 Million	-15,320 Reduced 67.03%	7,535 $703,000
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $5.93 Million - $6.91 Million	-52,744 Reduced 69.77%	22,855 $2.94 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $208,104 - $245,962	2,001 Added 2.72%	75,599 $8.78 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $753,602 - $1.09 Million	-8,868 Reduced 10.75%	73,598 $8.33 Million
Q3 2022 Nov 15, 2022	SELL	$76.35 - $94.18 $4.45 Million - $5.48 Million	-58,238 Reduced 41.39%	82,466 $6.64 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $9.27 Million - $18.1 Million	136,336 Added 3121.25%	140,704 $10.5 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $1.56 Million - $2.15 Million	-16,537 Reduced 79.11%	4,368 $2.24 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $2.71 Million - $3.4 Million	20,905 New	20,905 $11.2 Million
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $5.13 Million - $6.83 Million	-63,299 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $497,293 - $614,300	5,865 Added 10.21%	63,299 $22.7 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $4.48 Million - $6 Million	57,434 New	57,434 $21.2 Million
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $1.14 Million - $1.35 Million	-11,920 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$62.68 - $105.34 $66,440 - $111,660	1,060 Added 9.76%	11,920 $4.83 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $518,999 - $821,341	10,860 New	10,860 $2.92 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $525,057 - $821,424	-14,338 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $509,429 - $628,004	14,338 New	14,338 $2.14 Million
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $299,049 - $414,059	-11,080 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$23.35 - $36.72 $33,624 - $52,876	-1,440 Reduced 11.5%	11,080 $1.59 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $219,600 - $315,754	12,520 New	12,520 $1.19 Million

Others Institutions Holding DXCM

# of Institutions

1,078

Shares Held

351M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $35B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account

Jacobs Levy Equity Management, Inc Dexcom Inc Transaction History